Pulse Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview

Pulse Biosciences

04/08/2026 22:22

Pulse Biosciences Inc PLSE.OQ PLSE.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The Hayward California-based  company is expected to report revenue of $533.33 thousand, according to the mean estimate from 3 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Pulse Biosciences Inc is for a loss of 36 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Pulse Biosciences Inc is $32.00, about 15.2% below its last closing price of $37.73
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.32
-0.31
-0.24
Beat
23.8
Dec. 31 2026
-0.31
-0.31
-0.26
Beat
16.1
Sep. 30 2025
-0.31
-0.31
-0.29
Beat
6.5​
Jun. 30 2025
-0.26
-0.26
-0.20
Beat
23.1
​​
​
This summary was machine generated August 4 at 21:22 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)